Increasing global temperatures are ruining sleep quality across the world. Sleep apnea, a common breathing disorder, is ...

With more than 1 in 10 Americans suffering from obstructive sleep apnea putting them at increased risk of heart problems and ...

And the severe cases — when people stop breathing more than 30 times in a single hour — go up, too. "You also increase the ...

Rising temperatures may make sleep apnea worse, researchers say.Getty Images Editor at Large We all have cause to take climate change personally. Not only do higher temperatures lead to such mega ...

Sleep apnea is a common sleep disorder where breathing repeatedly stops and starts during sleep, often due to a blocked airway or poor brain signaling. Getty Images/iStockphoto.

New research from the National Sleep Foundation finds that nearly 90% of Americans said sleep apnea is a serious condition, but nearly one-third diagnosed are not currently being treated.

Sleep apnea is thought to be fairly widespread in the U.S., but it’s also underknown and underdiagnosed, Hutchison said. The American Medical Association estimates that 30 million Americans ...

It's estimated that around 80% of sleep apnea cases in America remain undiagnosed. While current testing procedures are accurate, they're uncomfortable and sometimes hard to access. That could be ...

May 8 (UPI) --Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.The drop in blood oxygen levels that occurs during a sleep ...

Mouth taping may help with snoring and sleep apnea. Here’s how to do it. Sealing the mouth with tape has made its way across Instagram and TikTok, and into season 7 of the popular reality show ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

The FDA said Zepbound’s approval for moderate to severe obstructive sleep apnea in adults with obesity is based on two placebo-controlled studies of 469 adults without type 2 diabetes.